Bastien Amanda J, Manzoor Daniel, Maluf Horacio, Balzer Bonnie, Leong Matthew, Walgama Evan S, Scher Kevin C, Jang Julie K, Moyers Justin, Clair Jon Mallen-St, Zumsteg Zachary S, Ho Allen S
Division of Otolaryngology-Head and Neck Surgery, Dept. of Surgery, Cedars-Sinai Medical Center, United States.
Samuel Oschin Comprehensive Cancer Institute, United States; Department of Pathology, Cedars-Sinai Medical Center, United States.
Oral Oncol. 2025 Jun;165:107286. doi: 10.1016/j.oraloncology.2025.107286. Epub 2025 Apr 25.
With a deeper understanding of histopathologic assessment, head and neck oncology specialists (surgical oncologists, radiation oncologists, and medical oncologists) will be better equipped to address the increasing complexity encompassing head and neck cancer management.
Histopathologic assessment of surgical specimens imparts crucial information that is essential for post-operative treatment planning and prognostication for patients with head and neck squamous cell carcinoma (HNSCC). Herein, we discuss the most current guidelines and recommendations to elucidate the clinically relevant histopathologic features in HNSCC. This review discusses the following pathology features: extranodal extension, margins, perineural invasion, histologic grade, dysplasia, depth of invasion, lymphovascular invasion, and other considerations such as p16 immunohistochemistry, HPV in situ hybridization and worst pattern of invasion.
Understanding histopathology in HNSCC is essential for accurate diagnosis, prognostication, understanding tumor behavior, and treatment management. This complexity of care has led to consensus guidelines from numerous authorities which this paper discusses and summarizes for readers.
The understanding of key histopathology elements in HNSCC will augment multidisciplinary discussions and improve patient care. The current variability in existing consensus guidelines highlights the need for improved standardization of histopathology reporting in HNSCC. Standardization will enhance diagnostic accuracy, guide clinical decision-making, and facilitate the development of more effective treatment strategies.
通过更深入地理解组织病理学评估,头颈肿瘤学专家(外科肿瘤学家、放射肿瘤学家和医学肿瘤学家)将更有能力应对头颈癌管理日益增加的复杂性。
手术标本的组织病理学评估提供了关键信息,这对于头颈部鳞状细胞癌(HNSCC)患者的术后治疗计划和预后至关重要。在此,我们讨论最新的指南和建议,以阐明HNSCC中临床相关的组织病理学特征。本综述讨论以下病理学特征:结外扩展、切缘、神经周围侵犯、组织学分级、发育异常、浸润深度、脉管侵犯以及其他考虑因素,如p16免疫组织化学、HPV原位杂交和最差浸润模式。
了解HNSCC的组织病理学对于准确诊断、预后评估、理解肿瘤行为和治疗管理至关重要。这种护理的复杂性导致了众多权威机构的共识指南,本文对此进行了讨论并为读者进行了总结。
对头颈鳞状细胞癌关键组织病理学要素的理解将加强多学科讨论并改善患者护理。现有共识指南目前的变异性凸显了对头颈鳞状细胞癌组织病理学报告进行更好标准化的必要性。标准化将提高诊断准确性、指导临床决策并促进更有效治疗策略的制定。